This was also in agreement with previously reported associations between FABP2 genetic polymorphism and dyslipidaemia (high plasma concentration of TGs and low concentration of HDL) and MS in elderly subjects ﻿[47–50]. The gene discussed is FABP2; the disease is myeloid sarcoma.